Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.

Neoplasma - 1 Jan 1999

Smardová J, Vagunda V, Jandáková E, Vagundová M, Koukalová H, Kovarík J, Zaloudík J

Abstract excerpt

The prognostic and predictive value of p53 mutation in breast cancer is still conflicting. The choice of the p53 status detection method may account for some discrepancies. In this pilot study we compared two differently-based methods for detection of p53 alteration in 32 breast carcinoma samples: the immunohistochemical method using Bp53, DO1 and DO11 monoclonal antibodies for analysis of the p53 protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Sensitivity and Specificity

Share to Transcriptional Activation

Share to Tumor Cells, Cultured

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10732868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.PMID 10732868Read ↗

Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry.Semantic proximity Read ↗

Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.Semantic proximity Read ↗

Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.Semantic proximity Read ↗

Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay.Semantic proximity Read ↗

Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.Semantic proximity Read ↗

Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma.Semantic proximity Read ↗

Rare somatic p53 mutation identified in breast cancer: a case report.Semantic proximity Read ↗

p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours.Semantic proximity Read ↗

Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratory.Semantic proximity Read ↗

[Analyses of p53 mutations in breast cancers with a combined use of yeast functional assay and immunohistochemical staining].Semantic proximity Read ↗

Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.Semantic proximity Read ↗

Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.